Task: Question Answering
Input (English): Context: During colitis, epithelial function is impaired, leading to increased bacterial translocation. Recent studies have shown the important role of proinflammatory cytokines and chemokines, including RANTES (regulated on activation, normal T-cell expressed and secreted), in inflammatory bowel diseases (IBDs). In this study, we evaluated the role of Met-RANTES, an antagonist of the RANTES receptor, on the impairment of bacterial translocation in a rat model of colitis.', 'Rats were randomly assigned to 3 groups. Group 1 = control, group 2 = experimental colitis, and group 3 = colitis plus Met-RANTES treatment. On day 7 after colitis was induced, plasma tumor necrosis factor-alpha colon tissue myeloperoxidase and portal blood endotoxin levels were measured. Lymph node, liver, and spleen culture quantified bacterial translocation.', 'Met-RANTES treatment resulted in significant decreases in colonic damage as well as bacterial translocation in experimental colitis.\Question: Does treatment with Met-RANTES decrease bacterial translocation in experimental colitis?
Output (English): These results suggest that chemokine receptor antagonists may potentially be useful in the treatment of IBDs.